Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Mildred Iro, a Paediatric Research Fellow working with the Oxford Vaccine Group, won the Lorber Prize for the best paediatric publication of 2017 for her work on childhood encephalitis admissions.

The winning paper, published in Lancet in April 2017, examined trends in hospital admission rates for encephalitis in children over a 33-year period (1979-2011). The results show that while hospital admission rates for all instances of childhood encephalitis in England increased between 1995 and 2011, admissions for mumps encephalitis decreased by 98%, and for measles by 97%, after the introduction of the two-dose MMR vaccination schedule. Mildred’s study is the first to quantify the effect of the MMR vaccine on childhood measles and mumps encephalitis admissions in England. It is also the first to define the incidence of all-cause childhood encephalitis in England.

Mildred Iro joined Oxford University’s Department of Paediatrics in 2012; in 2013 she commenced her DPhil at the Oxford Vaccine Group. She has done most of her paediatric training in Southampton, where she is planning to return after the completion of her doctorate to take up the position of an NIHR Academic Clinical Lecturer in Child Health and Genomics.

The Lorber Prize is given annually by the Royal College of Paediatrics and Child Health. The award honours a pre-consultant grade medical practitioner working in the UK for the best scientific paper related to paediatrics.

 

Similar stories

Oxford Vaccine Group among winners at NHS Parliamentary awards

Researchers behind the Oxford AstraZeneca coronavirus vaccine have been recognised for their excellence at a healthcare awards ceremony.

New book highlights life-saving role vaccines play in prevention of killer diseases

'Brain Fever', a new book by internationally-renowned medical scientist Professor Richard Moxon, describes the decades of research that contribute to the development of vaccines for life-threatening illnesses such as meningitis, and how immunisation has been our greatest public health intervention.

Delayed second dose and third doses of the Oxford-AstraZeneca vaccine lead to heightened immune response

Research on the ChAdOx1 nCoV-19, also known as the Oxford-AstraZeneca vaccine, indicates that a long interval between first and second doses does not compromise the immune response after a late second dose.

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

How do childhood vaccination policies vary across the world?

Read about the topic in Samantha Vanderslott's latest publication.

OVG's director recognised in Queen’s Birthday Honours

Andrew Pollard, Director of the Oxford Vaccine Group, and Professor of Paediatric Infection and Immunity, becomes a Knight Bachelor for services to Public Health, particularly during the COVID-19 Pandemic.